Table 3 Factors influencing the occurrence of thromboembolism
Number of patients | Occurrence of thromboembolism, yes | Univariate analysis | Multivariate analysis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | ||||||||||
OR | 95% CI | P-valuea) | OR | 95% CI | P-value | OR | 95% CI | P-value | |||
Sex (female) | 76 | 9 | 1.12 | 0.39–3.17 | 0.815 | ||||||
Age (≧65 years) | 110 | 15 | 2.01 | 0.65–7.44 | 0.228 | ||||||
Primary lesion (Rectum) | 61 | 7 | 1.05 | 0.33–3.02 | 1.000 | ||||||
Metastasis in other organs, yes | 131 | 17 | 2.23 | 0.60–12.44 | 0.287 | ||||||
Comorbid cardiac disease, yes | 5 | 2 | 5.68 | 0.45–53.13 | 0.096 | ||||||
CV port expansion, yes | 155 | 20 | inf | 0.81–inf | 0.080 | ||||||
Use of VEGF inhibitors, yes | 134 | 12 | 0.46 | 0.16–1.39 | 0.110 | 0.48 | 0.18–1.31 | 0.153 | |||
Use of EGFR inhibitors, yes | 45 | 8 | 2.19 | 0.72–6.34 | 0.110 | 2.07 | 0.76–5.60 | 0.153 | |||
Risk factors for occurrence of thromboembolism≧1 | 70 | 14 | 4.26 | 1.44–14.30 | 0.003 | 4.17 | 1.51–11.50 | 0.006 | 4.17 | 1.51–11.50 | 0.006 |